Advertisement!
Author Information Pack
Editorial Board
Submit article
Special Issue
Editor's selection process
Join as Reviewer/Editor
List of Reviewer
Indexing Information
Most popular articles
Purchase Single Articles
Archive
Free Online Access
Current Issue
Recommend this journal to your library
Advertiser
Accepted Articles
Search Articles
Email Alerts
FAQ
Contact Us
Indian Journal of Anesthesia and Analgesia

Volume  6, Issue 5, September-October 2019, Pages 1766-1769
 

Original Article

A Study on Bupivacaine and Bupivacaine Plus Midazolam for Caudal analgesia in Children's

Olugumanu Srinivas Kumar1, Donthu Balaji2, G Obulesu3

1,2Assistant Professor, Department of Anesthesiology, Rajiv Gandhi Institute of Medical Science, Kadapa, Andhra Pradesh 516002, India. 3Assistant Professor, Department of Anesthesiology, Kerala Medical College and Hospital, Palakkad, Mangode, Kerala 679503, India.

Choose an option to locate / access this Article:
60 days Access
Check if you have access through your login credentials.        PDF      |
|

Open Access: View PDF

DOI: http://dx.doi.org/10.21088/ijaa.2349.8471.6519.39

Abstract

Pain is the commonest and most troubling impact of sickness and medical procedure. It has been an extraordinary test and worry to analysts. Entirely torment is an unmeasurable substance and any plan for its evaluation in man must be available to both subjects and spectator mistake. Aim of our study was to study on Bupivacaine and Bupivacaine plus Midazolam for caudal analgesia in children’s. Materials and Methods: The examination was embraced in 60 patients between the age gathering of 3 months and 12 years, and weighing between 4.5 kg and 25 kg, experiencing the elective medical procedures performed beneath the umbilical region. Conclusion: Caudal additional dural course has been favored in youngsters for its higher consistency, as respects to specialized parts of area of room and viability of relief from discomfort with medications regulated by this course.


Keywords : Bupivacaine; Bupivacaine plus Midazolam.
Corresponding Author : Donthu Balaji